HRP20090583T1 - Novi laktobacil, pripravak laktobacila koji se aktivira u živom organizmu, te preventivno ili terapijsko sredstvo protiv infekcija kod živog organizma - Google Patents
Novi laktobacil, pripravak laktobacila koji se aktivira u živom organizmu, te preventivno ili terapijsko sredstvo protiv infekcija kod živog organizma Download PDFInfo
- Publication number
- HRP20090583T1 HRP20090583T1 HR20090583T HRP20090583T HRP20090583T1 HR P20090583 T1 HRP20090583 T1 HR P20090583T1 HR 20090583 T HR20090583 T HR 20090583T HR P20090583 T HRP20090583 T HR P20090583T HR P20090583 T1 HRP20090583 T1 HR P20090583T1
- Authority
- HR
- Croatia
- Prior art keywords
- preventive
- lactobacillus
- therapeutic agent
- species
- living body
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract 7
- 241000186660 Lactobacillus Species 0.000 title claims abstract 6
- 229940039696 lactobacillus Drugs 0.000 title claims abstract 5
- 239000003814 drug Substances 0.000 title claims 6
- 230000003449 preventive effect Effects 0.000 title claims 6
- 229940124597 therapeutic agent Drugs 0.000 title claims 6
- 230000003213 activating effect Effects 0.000 title 1
- 244000199866 Lactobacillus casei Species 0.000 claims abstract 4
- 239000003242 anti bacterial agent Substances 0.000 claims abstract 2
- 230000003115 biocidal effect Effects 0.000 claims abstract 2
- 241001465754 Metazoa Species 0.000 claims 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 239000000645 desinfectant Substances 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 1
- -1 Fe3+ ions Chemical class 0.000 claims 1
- 239000002211 L-ascorbic acid Substances 0.000 claims 1
- 235000000069 L-ascorbic acid Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000249 desinfective effect Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims 1
- 208000028169 periodontal disease Diseases 0.000 claims 1
- 235000010199 sorbic acid Nutrition 0.000 claims 1
- 239000004334 sorbic acid Substances 0.000 claims 1
- 229940075582 sorbic acid Drugs 0.000 claims 1
- 241000894007 species Species 0.000 abstract 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003833 bile salt Substances 0.000 abstract 1
- 229940093761 bile salts Drugs 0.000 abstract 1
- 230000001364 causal effect Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003203802 | 2003-07-30 | ||
| PCT/JP2004/010639 WO2005012503A1 (ja) | 2003-07-30 | 2004-07-27 | 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090583T1 true HRP20090583T1 (hr) | 2009-12-31 |
Family
ID=34113630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090583T HRP20090583T1 (hr) | 2003-07-30 | 2009-10-30 | Novi laktobacil, pripravak laktobacila koji se aktivira u živom organizmu, te preventivno ili terapijsko sredstvo protiv infekcija kod živog organizma |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7863033B2 (de) |
| EP (1) | EP1661982B1 (de) |
| JP (1) | JP4661593B2 (de) |
| KR (1) | KR100763257B1 (de) |
| CN (1) | CN1842588B (de) |
| AT (1) | ATE442154T1 (de) |
| AU (1) | AU2004261832B2 (de) |
| BR (1) | BRPI0413008B8 (de) |
| CA (1) | CA2534013C (de) |
| DE (1) | DE602004023098D1 (de) |
| ES (1) | ES2332411T3 (de) |
| HK (1) | HK1095605A1 (de) |
| HR (1) | HRP20090583T1 (de) |
| IN (1) | IN2006MU00214A (de) |
| MX (1) | MXPA06001167A (de) |
| RU (1) | RU2340669C2 (de) |
| UA (1) | UA88271C2 (de) |
| WO (1) | WO2005012503A1 (de) |
| ZA (1) | ZA200600866B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101525633B (zh) * | 2009-04-13 | 2012-01-04 | 天津科技大学 | 一种乳杆菌产抗植物致病真菌发酵液的制备方法 |
| JP5612870B2 (ja) * | 2010-02-26 | 2014-10-22 | コンビ株式会社 | 褥瘡改善作用を有する組成物 |
| RU2465322C2 (ru) * | 2010-12-09 | 2012-10-27 | Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) | ШТАММ БАКТЕРИЙ Lactobacillus casei/paracasei - ВГНКИ 10.02.62 ДЕП, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРИГОТОВЛЕНИЯ ПРОБИОТИЧЕСКОЙ ДОБАВКИ |
| EP2578088A1 (de) * | 2011-10-06 | 2013-04-10 | Nestec S.A. | Essbares Netz mit Mikroorganismen |
| CN105338819A (zh) | 2013-06-27 | 2016-02-17 | 星巴克公司，贸易用名星巴克咖啡公司 | 用于饮料和其他食品的生物保存方法 |
| CN104293691B (zh) * | 2014-06-13 | 2017-09-19 | 杨雄 | 一株能降低抗药性的嗜酸乳杆菌及其制备的生物制剂 |
| JP5703513B1 (ja) * | 2014-11-05 | 2015-04-22 | 沖縄ハム総合食品株式会社 | 新規乳酸菌株及びその乳酸菌株による発酵組成物及び醗酵エキス |
| CN105362297B (zh) * | 2015-09-22 | 2019-03-08 | 福建贝迪药业有限公司 | 一种用于防控雏禽肠道病原的复合微生态制剂及其制备方法 |
| US10363279B2 (en) * | 2016-02-20 | 2019-07-30 | Nubiome, Inc. | Treatment and prophylaxis for neurological conditions and diseases |
| BE1024189B1 (nl) | 2016-10-28 | 2017-12-05 | Yun NV | Spuitbus met bacteriële species |
| BR112019019734A2 (pt) | 2017-03-23 | 2020-04-14 | Ku Leuven Res & Development | cepa probiótica de lactobacillus casei e usos da mesma |
| WO2019216438A1 (ja) * | 2018-05-11 | 2019-11-14 | 株式会社セルテクノロジー | 間葉系細胞の培養上清を含む歯周病治療剤 |
| CN109943507B (zh) * | 2019-03-26 | 2021-08-17 | 中国兽医药品监察所 | 一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4716791B1 (de) * | 1968-10-20 | 1972-05-17 | ||
| JPS52102419A (en) * | 1976-02-23 | 1977-08-27 | Seikenkai | Lactic acid producing bacillus preparation |
| GB1585863A (en) | 1977-08-24 | 1981-03-11 | Seiken Kai Foundational Juridi | Pharmaceutical lactobacillus preparations |
| DE2738652C3 (de) | 1977-08-26 | 1981-02-19 | Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) | Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen |
| FR2400901A1 (fr) | 1977-08-26 | 1979-03-23 | Seiken Kai Foundational Juridi | Preparations pharmaceutiques de lactobacillus, utiles notamment comme anti-infectieux |
| US4579740A (en) * | 1983-07-11 | 1986-04-01 | Microlife Technics, Inc. | Fermentation method using a selected lactobacillus |
| JP3958456B2 (ja) * | 1998-12-25 | 2007-08-15 | 高梨乳業株式会社 | 血清脂質改善効果を有する機能性飲食品 |
| JP2000217566A (ja) * | 1999-01-25 | 2000-08-08 | Bhph Co Ltd | ラクトバチラスクリアランスを培養するための培養基および該菌種の保存方法 |
| JP4193269B2 (ja) * | 1999-03-04 | 2008-12-10 | ビーエイチピーエイチ カンパニーリミテッド | 新規な生体浄化活性型乳酸菌製剤 |
| EP1038951A1 (de) * | 1999-03-23 | 2000-09-27 | Societe Des Produits Nestle S.A. | Synthetisches Mittel für die Züchtung von Lactobacillus und/oder die Bifidobacterien |
| ATE272320T1 (de) * | 1999-04-30 | 2004-08-15 | Nestle Sa | Erhöhtes wachstum von milchsäurebakterien im milch |
| JP4193330B2 (ja) * | 2000-05-24 | 2008-12-10 | ビーエイチピーエイチ カンパニーリミテッド | 新規な感染症対応型乳酸菌および該乳酸菌を主成分とした乳酸菌製剤 |
| KR100419132B1 (ko) * | 2000-12-29 | 2004-02-18 | 조성근 | 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01 |
| JP4528472B2 (ja) | 2001-11-29 | 2010-08-18 | ビオフェルミン製薬株式会社 | 歯周病の予防または治療剤 |
-
2004
- 2004-07-27 WO PCT/JP2004/010639 patent/WO2005012503A1/ja active Application Filing
- 2004-07-27 ES ES04770950T patent/ES2332411T3/es active Active
- 2004-07-27 CN CN2004800223610A patent/CN1842588B/zh active Active
- 2004-07-27 EP EP04770950A patent/EP1661982B1/de active Active
- 2004-07-27 CA CA2534013A patent/CA2534013C/en not_active Expired - Fee Related
- 2004-07-27 JP JP2005512490A patent/JP4661593B2/ja active Active
- 2004-07-27 UA UAA200602009A patent/UA88271C2/uk unknown
- 2004-07-27 AT AT04770950T patent/ATE442154T1/de not_active IP Right Cessation
- 2004-07-27 ZA ZA200600866A patent/ZA200600866B/en unknown
- 2004-07-27 AU AU2004261832A patent/AU2004261832B2/en not_active Ceased
- 2004-07-27 RU RU2006106279/13A patent/RU2340669C2/ru not_active IP Right Cessation
- 2004-07-27 DE DE602004023098T patent/DE602004023098D1/de active Active
- 2004-07-27 US US10/566,085 patent/US7863033B2/en active Active
- 2004-07-27 BR BRPI0413008A patent/BRPI0413008B8/pt not_active IP Right Cessation
- 2004-07-27 KR KR20067002032A patent/KR100763257B1/ko active IP Right Grant
-
2006
- 2006-01-30 MX MXPA06001167 patent/MXPA06001167A/es active IP Right Grant
- 2006-02-16 IN IN214MU2006 patent/IN2006MU00214A/en unknown
-
2007
- 2007-03-16 HK HK07102844.7A patent/HK1095605A1/xx unknown
-
2009
- 2009-10-30 HR HR20090583T patent/HRP20090583T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1842588B (zh) | 2010-09-29 |
| CA2534013C (en) | 2010-11-02 |
| KR100763257B1 (ko) | 2007-10-04 |
| EP1661982A4 (de) | 2007-03-14 |
| UA88271C2 (uk) | 2009-10-12 |
| RU2340669C2 (ru) | 2008-12-10 |
| RU2006106279A (ru) | 2006-08-27 |
| AU2004261832A1 (en) | 2005-02-10 |
| EP1661982B1 (de) | 2009-09-09 |
| MXPA06001167A (es) | 2006-10-30 |
| ES2332411T3 (es) | 2010-02-04 |
| WO2005012503A1 (ja) | 2005-02-10 |
| US7863033B2 (en) | 2011-01-04 |
| BRPI0413008A (pt) | 2006-10-17 |
| DE602004023098D1 (de) | 2009-10-22 |
| CN1842588A (zh) | 2006-10-04 |
| IN2006MU00214A (de) | 2007-06-15 |
| CA2534013A1 (en) | 2005-02-10 |
| JPWO2005012503A1 (ja) | 2007-09-27 |
| BRPI0413008B1 (pt) | 2017-06-20 |
| US20080293126A1 (en) | 2008-11-27 |
| AU2004261832B2 (en) | 2007-10-04 |
| BRPI0413008B8 (pt) | 2021-05-25 |
| JP4661593B2 (ja) | 2011-03-30 |
| EP1661982A1 (de) | 2006-05-31 |
| ZA200600866B (en) | 2007-04-25 |
| ATE442154T1 (de) | 2009-09-15 |
| HK1095605A1 (en) | 2007-05-11 |
| KR20060037412A (ko) | 2006-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090583T1 (hr) | Novi laktobacil, pripravak laktobacila koji se aktivira u živom organizmu, te preventivno ili terapijsko sredstvo protiv infekcija kod živog organizma | |
| Barnes et al. | An assessment of the antibacterial activity in larval excretion/secretion of four species of insects recorded in association with corpses, using Lucilia sericata Meigen as the marker species | |
| JP3875262B2 (ja) | 殺菌剤としての酸性化したニトリット | |
| WO2004030624A3 (en) | Compositions and methods for inhibiting pathogenic growth | |
| CA2627430A1 (en) | Growth control of oral and superficial microorganisms using gallium compounds | |
| DE69930944D1 (de) | Bacillus coagulans-zusammensetzung und deren verwendung | |
| CN109364100A (zh) | 一种高效抗菌的纳米硫化铁混合物及其制备方法和应用 | |
| CA2503130A1 (en) | Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens | |
| JP2009514861A5 (de) | ||
| US20200318151A1 (en) | Method for producing microbial probiotic biofilms and uses thereof | |
| CN109260222A (zh) | 半胱氨酸基抗菌纳米硫化铁混合物及其制备方法和应用 | |
| DE60023846D1 (de) | Ein verfahren zur bekämpfung pilzlicher pathogene und dafür brauchbare mittel | |
| KR101908220B1 (ko) | 리포테이코산 및 항생제를 포함하는 생물막 형성 방지 또는 저해용 조성물 | |
| Piskaeva et al. | Comparative analysis of the activity of silver nanoparticles against native microflora from poultry processing plants wastes | |
| JP2022075278A (ja) | コロナウイルス（例えば、ＳＡＲＳ－ＣｏＶ－２）を含む広範な微生物に有用な抗微生物剤 | |
| Sinha et al. | Bdellovibrio like organisms: the predatory assassin | |
| Goudarzi et al. | evaluation of antimicrobial activity of probiotic lactobacillus strains against growth and urease activity of proteus spp. | |
| Sharma et al. | Bacteriological analysis of bile culture from a tertiary care hospital | |
| CN101926830B (zh) | 一种抗菌剂 | |
| Ebenezer et al. | A surge in anti-bacterial and anti-inflammatory activity of Sepia pharaonis ink extract in different solvents-an in-vitro study | |
| RU2439142C1 (ru) | Синтетическая питательная среда для выращивания микроорганизмов | |
| Valdenassi et al. | Oxygen-ozone activity in making factory farms antibiotic-free for prevention of antibiotic resistance | |
| Duran et al. | The Evaluation of the Antibacterial Effect of Silver Anode Treatment on Raw Milk | |
| Nalwade et al. | Food and Pharmaceuticals | |
| SK289178B6 (sk) | Kmeň mikroorganizmov Weissella cibaria 4/8 D37 CCM 9015, bakteriálna kultúra, bezbunkový supernatant kmeňa a farmaceutická kompozícia obsahujúca tento kmeň |